Venous thromboembolism: Understanding psychosocial factors and mental health of the patient

Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the United States, affecting up to 900,000 people and accounting for up to 100,000 deaths annually. The focus of care for patients once diagnosed with blood clots is to prevent recurrent VTE, major bleeding, and death. While these are highly relevant clinical outcomes, they do not capture patient-centered outcomes such as quality of life (QoL). Importantly, decreased QoL is prevalent after VTE, occurring in up to half of patients. Post-VTE syndrome occurs despite adequate anticoagulation therapy, ranging from mild to severe symptoms, and can have a major impact on QoL. Moreover, post-VTE syndrome has been associated with higher risk of depressive disorders, unemployment, and social isolation.

In this webinar, two clinical experts will present data and discuss the importance of understanding psychosocial factors that can affect patients’ diagnoses and long-term recovery from VTE.

Presented by 

Rachel P. Rosovsky, MD, MPH
Director, Thrombosis Research Division of Hematology, Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School

Jeffrey A. Kline, MD
Associate Chair for Research
Brooks Bock Endowed Professor, Wayne State University School of Medicine, Department of Emergency Medicine

Learning objectives

1. Describe why patient-centered outcomes are important during VTE care.
2. Describe how to use empathy to positively affect VTE patient care.
3. List an “always” and “never” statement to make to a patient with newly diagnosed VTE.

Registration

This webinar is free and open to health-care providers, pharmacists and public health researchers who desire more information about bleeding disorders. Additional event details and a registration link are available on the Centers for Disease Control and Prevention website Save The Date - Venous Thromboembolism | NCBDDD | CDC.